In re: Lipitor Antitrust Lit v.

• Court: Court of Appeals for the Third Circuit
• Decided: April 19, 2017
• Docket: 14-4202
• Status: Published

Opinion

PRECEDENTIAL

UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT ______

Nos. 14-4202, 14-4203, 14-4204, 14-4205, 14-4206, 14-4602 & 14-4632 ______

IN RE: LIPITOR ANTITRUST LITIGATION

Rite Aid Corporation; Rite Aid Hdqtrs. Corporation; JC (PJC) USA, LLC; Maxi Drug, Inc. d/b/a Brooks Pharmacy; Eckerd Corporation, Appellants in No. 14-4202

Walgreen Company; The Kroger Co.; Safeway, Inc.; Supervalu, Inc.; HEB Grocery Company L.P., Appellants in No. 14-4203

Giant Eagle, Inc., Appellant in No. 14-4204

Meijer, Inc.; Meijer Distribution, Inc., Appellants in No. 14-4205

Rochester Drug Co-Operative, Inc.; Stephen L. LaFrance Pharmacy, Inc. d/b/a SAJ Distributors; Burlington Drug Company, Inc.; Value Drug Company; Professional Drug Company, Inc.; American Sales Company LLC, Appellants in No. 14-4206 A.F.L.-A.G.C. Building Trades Welfare Plan; Mayor and City Council of Baltimore, Maryland; New Mexico United Food and Commercial Workers Union’s and Employers’ Health and Welfare Trust Fund; Louisiana Health Service Indemnity Company, d/b/a Blue Cross/Blue Shield of Louisiana; Bakers Local 433 Health Fund; Twin Cities Bakery Workers Health and Welfare Fund; Fraternal Order of Police, Fort Lauderdale Lodge 31, Insurance Trust Fund; International Brotherhood of Electrical Workers Local 98; New York Hotel Trades Counsel & Hotel Association of New York City, Inc., Health Benefits Fund; Edward Czarnecki; Emilie Heinle; Frank Palter; Andrew Livezey; Edward Ellenson; Jean Ellyne Dougan; Nancy Billington, on behalf of themselves and all others similarly situated, Appellants in No. 14-4602

RP Healthcare, Inc.; Chimes Pharmacy, Inc.; James Clayworth, R.Ph., d/b/a Clayworth Pharmacy; Marin Apothecaries, Inc., d/b/a Ross Valley Pharmacy; Golden Gate Pharmacy Services, Inc., d/b/a Golden Gate Pharmacy; Pediatric Care Pharmacy, Inc.; Meyers Pharmacy, Inc.; Tony Mavrantonis R. Ph., d/b/a Jack’s Drugs; Tilley Apothecaries Inc., d/b/a Zweber’s Apothecary, Appellants in No. 14-4632

2 ______

Nos. 15-1184, 15-1185, 15-1186, 15-1187, 15-1274, 15-1323 & 15-1342 ______

IN RE: EFFEXOR XR ANTITRUST LITIGATION

Walgreen, Co.; The Kroger, Co.; Safeway, Inc.; Supervalu, Inc.; HEB Grocery Company LP; American Sales Company, Inc., Appellants in No. 15-1184

Rite Aid Corporation; Rite Aid Hdqtrs., Corporation; JCG (PJC) USA, LLC; Maxi Drug, Inc. d/b/a Brooks Pharmacy; Eckerd Corporation; CVS Caremark Corporation, Appellants in No. 15-1185

Giant Eagle, Inc., Appellant in No. 15-1186

Meijer, Inc.; Meijer Distribution, Inc., Appellants in No. 15-1187

Professional Drug Company, Inc.; Rochester Drug Co- Operative, Inc.; Stephen L. LaFrance Holdings, Inc.; Stephen L. LaFrance Pharmacy, Inc. d/b/a SAJ Distributors; Uniondale Chemist, Inc., Appellants in No. 15-1274

3 Painters District Council No. 30 Health & Welfare Fund; Medical Mutual of Ohio, Appellants in No. 15-1323

A.F.L.-A.G.C. Building Trades Welfare Plan; Daryl Deino; IBEW-NECA Local 505 Health & Welfare Plan; Louisiana Health Service Indemnity Company d/b/a Blue Cross/Blue Shield of Louisiana; Man-U Service Contract Trust Fund; MC-UA Local 119 Health & Welfare Plan; New Mexico United Food and Commercial Workers Union’s and Employers’ Health and Welfare Trust Fund; Plumbers and Pipefitters Local 572 Health and Welfare Fund; Sergeants Benevolent Association Health and Welfare Fund; Patricia Sutter (together “End-Payor Class Plaintiffs”) on behalf of themselves and all others similarly situated, Appellants in No. 15-1342 ______

On Appeal from the United States District Court for the District of New Jersey

(MDL 2332) / (D.N.J. No. 3-12-cv-02389) / (D.N.J. No. 3- 12-cv-02478) / (D.N.J. No. 3-12-cv-02519) / (D.N.J. No. 3- 12-cv-04115) / (D.N.J. No. 3-12-cv-04537) / (D.N.J. No. 3- 12-cv-05129) / (D.N.J. No. 3-12-cv-06774) / (D.N.J. No. 3- 12-cv-07561) (D.N.J. No. 3-11-cv-05479) / (D.N.J. No. 3-11-cv-05590) / (D.N.J. No. 3-11-cv-05661) / (D.N.J. No. 3-11-cv-06985) / (D.N.J. No. 3-11-cv-07504) / (D.N.J. No. 3-12-cv-03116) / (D.N.J. No. 3-12-cv-03523) ______

ORDER AMENDING OPINION

4 ______

At the direction of the Court, the opinion filed on April 13, 2017 is amended as follows:

Page 21, first full paragraph, third line: is changed to .

Page 21, first full paragraph, ninth line: delete before .

Page 25, only full paragraph, second line: <'983 Patent> is changed to <'893 Patent>.

Page 28, fourth paragraph, fourth line: is changed to .

Page 31, second paragraph, fourth line: is changed to .

Page 43, first full paragraph, first line: is changed to .

5 Page 43, first full paragraph, tenth line: <(per curiam)> is added after .

Page 44, first full paragraph, first line: is changed to .

For the Court,

Marcia M. Waldron, Clerk Date: April 19, 2017

mlr/cc: all counsel